A detailed history of Lgt Financial Advisors LLC transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Lgt Financial Advisors LLC holds 87 shares of HRMY stock, worth $3,413. This represents 0.01% of its overall portfolio holdings.

Number of Shares
87
Previous 87 -0.0%
Holding current value
$3,413
Previous $2.92 Million 10.13%
% of portfolio
0.01%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 12, 2024

BUY
$19.2 - $33.78 $211 - $371
11 Added 14.47%
87 $2.81 Million
Q3 2023

Nov 01, 2023

BUY
$31.89 - $39.03 $2,423 - $2,966
76 New
76 $2.49 Million

Others Institutions Holding HRMY

About Harmony Biosciences Holdings, Inc.


  • Ticker HRMY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,161,400
  • Market Cap $2.32B
  • Description
  • Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...
More about HRMY
Track This Portfolio

Track Lgt Financial Advisors LLC Portfolio

Follow Lgt Financial Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lgt Financial Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lgt Financial Advisors LLC with notifications on news.